ERGT for Women Engaging in NSSI - an Effectiveness Study
Emotion Regulation Group Therapy (ERGT) for Women Engaging in Non-suicidal Self-Injury (NSSI) - an Effectiveness Study
1 other identifier
interventional
97
1 country
1
Brief Summary
The primary aim is to investigate the effectiveness of Emotion Regulation Group Therapy (ERGT) for women who self-harm in ordinary psychiatric outpatient health care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 4, 2013
CompletedFirst Posted
Study publicly available on registry
November 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedNovember 6, 2017
November 1, 2017
9 months
November 4, 2013
November 2, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Frequency of non-suicidal self-injury as measured by Deliberate Self-Harm Inventory (DSHI)
Change from Baseline in deliberate self-harm after 14 weeks and at 6- and 12 months after treatment has ended.
Baseline (from inclusion to treatment start), (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.
Secondary Outcomes (9)
Borderline Symptom List Behavior supplement (BSL-supplement)
Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks), and six and twelve months follow-up.
Difficulties in Emotion Regulation Scale (DERS)
Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.
Diary questionnaire (DQ)
Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.
The Borderline Evaluation of Severity over Time (BEST).
Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.
The Depression Anxiety Stress Scales (DASS)
Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.
- +4 more secondary outcomes
Study Arms (1)
Emotion Regulation Group Therapy (ERGT).
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- NSSI a minimum of three times in the last six months
- Meets at least three criteria for Borderline Personality Disorder according to DSM-IV-TR
- Contact with an other individual therapist, psychiatrist, "case manager" or equal
You may not qualify if:
- Insertion/withdrawal of psychopharmacological substances within two months prior to the treatment
- Other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in first hand
- Bipolar disorder I or primary psychosis
- Current substance dependence (the last month)
- Current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse)
- Insufficient Swedish language skills
- Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral therapy (DBT)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Psychiatry Research Karolinska Institutet and Stockholm County Council
Stockholm, 113 64, Sweden
Related Publications (1)
Sahlin H, Bjureberg J, Gratz KL, Tull MT, Hedman E, Bjarehed J, Jokinen J, Lundh LG, Ljotsson B, Hellner C. Emotion regulation group therapy for deliberate self-harm: a multi-site evaluation in routine care using an uncontrolled open trial design. BMJ Open. 2017 Oct 5;7(10):e016220. doi: 10.1136/bmjopen-2017-016220.
PMID: 28982814DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D.
Study Record Dates
First Submitted
November 4, 2013
First Posted
November 18, 2013
Study Start
October 1, 2013
Primary Completion
July 1, 2014
Study Completion
March 1, 2015
Last Updated
November 6, 2017
Record last verified: 2017-11